ENDONOVO THERAPEUTICS, INC. (ENDV) Net income 2013–2022
ENDONOVO THERAPEUTICS, INC. (ENDV) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$18.5MFY2022 · since FY2013: -$2.9M → -$18.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -$18.5M | -495.0% |
| FY2021 | -$3.1M | -684.9% |
| FY2020 | -$395,584 | +97.7% |
| FY2019 | -$17.3M | -169.0% |
| FY2018 | -$6.4M | +40.5% |
| FY2017 | -$10.8M | -103.4% |
| FY2016 | -$5.3M | +21.4% |
| FY2015 | -$6.8M | -605.1% |
| FY2014 | -$959,494 | +66.8% |
| FY2013 | -$2.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ENDV financial trends
ENDV RevenueENDV Net marginENDV Gross profitENDV Gross marginENDV Operating incomeENDV Operating marginENDV Operating cash flowENDV Free cash flowENDV Capital expendituresENDV Return on equityENDV Stock buybacksENDV Dividends paidENDV Total assetsENDV Total liabilitiesENDV Shareholders’ equityENDV overview →